Table 3. Multivariable analysis of factors associated with knowledge about HPV, its clinical repercussions and its vaccine among parents/guardians and adolescents interviewed during implementation of HPV vaccine.
Variables | Adolescents | P-value | Parents/guardians | P-value |
---|---|---|---|---|
RR (95% CI) | RR (95% CI) | |||
Sex | ||||
Male | 1.00 | 1.00 | ||
Female | 1.67 (1.10–2.60) | 0.023 | 0.89 (0.46–1.70) | 0.716 |
Age | ||||
From 10 to 14 | 1.00 | - | ||
From 15 to 19 | 1.39 (0.91–2.10) | 0.126 | - | |
From 20 to 39 | - | 1.00 | ||
From 40 to 59 | - | 1.11 (0.75–1.65) | 0.603 | |
Above 60 | - | 0.64 (0.23–1.80) | 0.399 | |
Profission | ||||
Employed | 1.00 | 1.00 | ||
Unemployed | 1.41 (0.69–2.88) | 0.348 | 0.64 (0.22–1.83) | 0.406 |
Education | ||||
Less than High School | 1.00 | 1.00 | ||
High School Complete or higher | 0.95 (0.48–1.91) | 0.900 | 3.38 (1.71–6.69) | <0.001 |
HPV Vaccination | ||||
Non-Vaccinated | 1.00 | 1.00 | ||
Vaccinated | 1.89 (1.25–2.85) | 0.002 | 1.33 (0.48–3.64) | 0.578 |
RR: Relative risk; 95% CI Confidence Interval; Poisson regression.
Childbirth omitted because of collinearity.